Xiaowei Qi
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Immune cells in cancer
Papers in
-
- Glycosylation and Glycoproteins Research 1
- RNA Interference and Gene Delivery 1
- Circular RNAs in diseases 1
- Oncology 6
- Cancer Treatment and Pharmacology 1
- Cancer Diagnosis and Treatment 1
- Co-authors
- Bojian Fei (2 shared papers)Dong Hua (1 shared paper)Zhaohui Huang (1 shared paper)Jiwei Zhang (1 shared paper)Leyuan Zhou (1 shared paper)Yuan Yin (1 shared paper)Min Li (1 shared paper)Yaling Hu (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)Medicine (1 paper)International Immunopharmacology (1 paper)Clinical Science (1 paper)Materials Today Bio (1 paper)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Xiaowei Qi
15 papers receiving 362 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 83
- Immunology 114
- Oncology 118
- Molecular Biology 163
- Sensory Systems 9
Countries citing papers authored by Xiaowei Qi
This map shows the geographic impact of Xiaowei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Qi more than expected).
Fields of papers citing papers by Xiaowei Qi
This network shows the impact of papers produced by Xiaowei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Qi. The network helps show where Xiaowei Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 213 | |
| 2 | 2015 | 40 | |
| 3 | 2016 | 28 | |
| 4 | 2015 | 22 | |
| 5 | 2019 | 21 | |
| 6 | 2018 | 10 | |
| 7 | 2018 | 10 | |
| 8 | 2022 | 6 | |
| 9 | 2024 | 4 | |
| 10 | 2019 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 3 | |
| 13 | 2025 | 1 | |
| 14 | 2022 | 1 | |
| 15 | Efficacy and adverse reactions of combination therapy of bevacizumab and 5-fluorouracil in patients with metastatic colon cancer. | 2019 | 1 |
| 16 | 2025 | 0 |
About Xiaowei Qi
Xiaowei Qi is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 16 papers that have together received 367 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Glycosylation and Glycoproteins Research (1 paper), Ferroptosis and cancer prognosis (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Cancer Treatment and Pharmacology (1 paper), RNA Interference and Gene Delivery (1 paper), Circular RNAs in diseases (1 paper) and Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (83 citations), Immunology (114 citations), Oncology (118 citations), Molecular Biology (163 citations) and Sensory Systems (9 citations). Xiaowei Qi has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Bojian Fei, Dong Hua, Zhaohui Huang, Jiwei Zhang, Leyuan Zhou, Yuan Yin, Min Li, Yaling Hu, Yan Qin and Zehua Bian. Their work appears in journals such as Clinical Cancer Research, Medicine, International Immunopharmacology, Clinical Science and Materials Today Bio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.